Website Terms and Conditions of Use
The following terms outline your access rights and responsibilities for use of noravexiuma’s website and property analysis services.
October 16, 2025
Acceptance of Terms
By using this site, you agree to comply with these terms, all applicable laws, and acknowledge that noravexiuma may update terms without notice. Continued use confirms your agreement to the latest version.
Definitions
Key terms below guide your understanding of these conditions and how they apply.
‘Service’ means market analysis, property reporting, or advisory provided by noravexiuma via this website or authorised communication channels.
‘User’ refers to anyone accessing, using, or communicating via noravexiuma.com or related platforms.
‘Content’ includes text, reports, downloadable resources, and information delivered via the website.
‘Agreement’ refers to these terms including any policy referenced within them.
Permitted Use of Services
Services are provided solely for your personal or business decision-making and may not be reproduced, sold, or repurposed without permission.
Eligibility
Site users must be at least 18 years old and able to form binding agreements under Australian law.
By continuing, you confirm you are eligible.
User Responsibilities
Your use of services implies agreement with responsible use standards outlined below.
Prohibited Uses
Certain behaviours are not allowed on this website.
Intellectual Property Rights
All content and trademarks remain the property of noravexiuma or its licensors. Use for commercial gain, modification, or distribution is prohibited unless explicitly authorized.
Your Content
Users may submit relevant information for service delivery; you retain ownership of your submissions.
User Submission Rights
By submitting content, you grant noravexiuma a non-exclusive right to use it in direct service provision only. Personal information is handled according to our privacy policy.
Respecting Your Privacy Commitment
noravexiuma complies with the Australian Privacy Principles in collecting and safeguarding personal information. For further details, read our privacy policy below.
View privacy policyService Disclaimer and Limitations
All reports and guidance provided are based on available data at the time. They do not constitute legal or financial advice; accuracy is subject to variation.
Results May Vary
Each property and market is unique. Outcomes from our analysis cannot be predicted or promised. Consult further professionals for legal or taxation queries.
Liability Limitations
noravexiuma excludes liability to the extent permitted by law for errors or omissions, including reliance on analysis or website content.
Indemnification
You agree to indemnify noravexiuma against any claims resulting from misuse or violation of these terms.
Resolving Disputes
Efforts to resolve disputes are encouraged through dialogue or negotiation first.
Arbitration
Should disputes remain unresolved, they may be referred to an agreed independent arbitrator.
Arbitration outcomes are binding and enforceable.
Online Dispute Resolution Explanation
Guidance about dispute resolution is available through relevant Australian legal bodies. See our dedicated disclaimer for more.
See our disclaimerSeverability
If a provision is found invalid, the remainder of the agreement remains effective.
Entire Agreement
These terms, together with all referenced policies, represent the entire agreement between you and noravexiuma.
Applicable Law Jurisdiction Scope
Terms are governed by the laws of New South Wales and applicable Australian statutes.
Termination
noravexiuma reserves the right to suspend or terminate site access for breaches of these terms or inappropriate conduct.
Changes
Updates or modifications to the terms will be posted here and apply immediately upon publication.
Contact noravexiuma for Clarification
Questions about these terms can be directed to our contact team below.
Contact email: content@noravexiuma.com
Phone number: +61307022045
Business address: 365 Little Collins St, Melbourne, VIC 3000 Australia
Effective from: October 16, 2025
Version: 2.1